In a recent government meeting, healthcare professionals highlighted the critical need for enhanced clinical research support in oncology, particularly emphasizing the role of nurses and advanced practice providers (APPs) in clinical trials. The discussion underscored a significant gap in the involvement of nurses with hematology-oncology and cellular therapy experience in clinical research, with a noted scarcity of APPs such as clinical nurse specialists and nurse practitioners.

One speaker, a research nurse at the Alpha Clinic, shared insights into the challenges faced in managing patient care across various settings, including inpatient units and outpatient clinics. The nurse emphasized the importance of bridging the gap between oncology and non-oncology treatments, particularly as more non-oncology trials emerge. This requires robust education and infrastructure to ensure patients receive comprehensive care without falling through the cracks.

The speaker detailed their multifaceted role, which includes supporting bedside nurses, ensuring they are well-informed about the clinical trials and therapies being administered. They expressed concern over the lack of education provided to nurses regarding complex therapies, which can lead to significant stress and potential risks for patients. The nurse's proactive approach involves constant communication with both patients and staff, utilizing various platforms to facilitate understanding and coordination of care.

Additionally, the speaker outlined their involvement from the initial stages of trial setup, including reviewing financial aspects and ensuring all team members are prepared for the trial launch. The emphasis on communication, education, and collaboration among healthcare providers was a recurring theme, highlighting the necessity for a cohesive approach to patient care in clinical research settings.

Overall, the meeting shed light on the urgent need for increased support and resources for nursing staff involved in clinical trials, aiming to improve patient outcomes and streamline the research process in oncology.